Ocean Sciences Ltd (ASX:OSS) has lodged an Appendix 3B disclosing a proposed issue of 6,363,637 ordinary fully paid shares and an equal number of attaching options in consideration for $70,000 in directors fees payable, with the proposed issue date set for 24 December 2026.

Key Points

  • 6,363,637 ordinary fully paid shares proposed to be issued at an AUD equivalent consideration of $0.011 per share in lieu of directors fees
  • 6,363,637 attaching options to be issued on a one-for-one basis, with an exercise price of $0.03 and expiry date of 24 December 2029
  • Proposed issue date is 24 December 2026, subject to securityholder approval by 23 December 2026
  • The issue is linked to resolutions 5 and 6 of an EGM notice lodged with ASX on 20 November 2026

Share Issue Terms and Consideration

According to the filing dated 20 November 2026, Ocean Sciences Ltd proposes to issue 6,363,637 ordinary fully paid shares as an existing class of securities. The shares are not being issued for cash consideration; instead, the consideration is directors fees payable, with an estimated AUD equivalent of $0.011 per share. The filing states the total purpose of the securities issue is to satisfy $70,000 in directors fees. The proposed securities will rank equally in all respects from their issue date with existing issued securities in the same class.

Attaching Options Structure

Alongside the ordinary shares, Ocean Sciences Ltd proposes to issue 6,363,637 attaching options as a new class of securities not yet quoted or recorded by ASX. The options are to be issued on a one-for-one basis with the shares. Each option carries an exercise price of AUD $0.03 and an expiry date of 24 December 2029, representing three years from the proposed issue date. Upon exercise, each option will convert into one ordinary fully paid share in the company. The company stated it will not be seeking quotation of the new class of options on ASX.

Securityholder Approval and Conditions

The filing discloses that securityholder approval is required before the placement can proceed on an unconditional basis, with the determination date set at 23 December 2026. The issue is subject to resolutions 5 and 6 of an EGM notice lodged with ASX on 20 November 2026. The filing confirms the issue will not use the entity's 15% placement capacity under listing rule 7.1 or its additional 10% placement capacity under listing rule 7.1A. No lead manager, broker, or underwriter is involved, and no other material fees or costs in connection with the proposed issue were disclosed.